Best Topoisomerase Inhibitor for carcinoma, non-small-cell lung
The 3 Topoisomerase Inhibitor options we list for carcinoma, non-small-cell lung are all Irinotecan Hydrochloride— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for carcinoma, non-small-cell lung or the full Topoisomerase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 3 topoisomerase inhibitor drugs we rate for carcinoma, non-small-cell lung, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for carcinoma, non-small-cell lung; the right choice depends on your situation, so confirm it with your prescriber.
How topoisomerase inhibitor work
Topoisomerase inhibitors target enzymes that cells rely on to cut and rejoin their DNA during cell division. By trapping these enzymes after they cut the DNA but before they can reseal it, the drugs leave the DNA broken, which halts cell division and kills rapidly dividing cancer cells.
Source: Topoisomerase Inhibitors - LiverTox - NCBI Bookshelf
Other drug classes for carcinoma, non-small-cell lung
These are all Irinotecan Hydrochloridein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 3 topoisomerase inhibitor products
camptosar
Boxed warningPrescriptionFDA-sourced
Camptosar (Irinotecan Hydrochloride) is a topoisomerase inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms, Leukemia.
Price varies
irinotecan hydrochloride
Boxed warningPrescriptionFDA-sourced
Irinotecan Hydrochloride is a topoisomerase inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms, Leukemia.
Price varies
onivyde
Boxed warningPrescriptionFDA-sourced
Onivyde (Irinotecan Hydrochloride) is a topoisomerase inhibitor used to treat Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Colonic Neoplasms, Leukemia.
Price varies
Frequently asked
- What is the best topoisomerase inhibitor for carcinoma, non-small-cell lung?
- The Topoisomerase Inhibitor options we list for carcinoma, non-small-cell lung are all Irinotecan Hydrochloride — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which topoisomerase inhibitor drugs treat carcinoma, non-small-cell lung?
- pharmaranks lists 3 Topoisomerase Inhibitor products used for carcinoma, non-small-cell lung, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.